Humana (HUM) Updates FY 2018 Earnings Guidance

Humana (NYSE:HUM) updated its FY 2018 earnings guidance on Wednesday. The company provided earnings per share guidance of $14.40-14.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.18. Humana also updated its FY18 guidance to ~$14.40 EPS.

A number of analysts recently commented on the company. MED reaffirmed an outperform rating and issued a $373.00 target price (up from $350.00) on shares of Humana in a research report on Thursday. Piper Jaffray Companies boosted their target price on Humana from $355.00 to $380.00 and gave the company an overweight rating in a research report on Friday, August 24th. Bank of America boosted their price objective on Humana from $338.00 to $375.00 and gave the stock a buy rating in a report on Thursday, August 2nd. Royal Bank of Canada reissued a hold rating and set a $318.00 price objective on shares of Humana in a report on Thursday, August 2nd. Finally, SunTrust Banks boosted their price objective on Humana to $380.00 and gave the stock a hold rating in a report on Wednesday, September 19th. Seven research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average target price of $352.30.

HUM traded down $14.39 during midday trading on Thursday, reaching $339.59. 1,067,167 shares of the company were exchanged, compared to its average volume of 747,680. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.43 and a current ratio of 1.43. The firm has a market capitalization of $45.71 billion, a P/E ratio of 29.00, a P/E/G ratio of 1.65 and a beta of 1.03. Humana has a one year low of $231.90 and a one year high of $355.88.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 7th. The insurance provider reported $4.58 EPS for the quarter, topping analysts’ consensus estimates of $4.29 by $0.29. The firm had revenue of $14.21 billion during the quarter, compared to analyst estimates of $13.97 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same period in the previous year, the company posted $3.39 EPS. On average, equities analysts forecast that Humana will post 14.18 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Stockholders of record on Monday, December 31st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.59%. The ex-dividend date is Friday, December 28th. Humana’s dividend payout ratio is presently 17.08%.

In other news, insider Elizabeth D. Bierbower sold 3,092 shares of the company’s stock in a transaction that occurred on Thursday, August 16th. The stock was sold at an average price of $330.00, for a total value of $1,020,360.00. Following the completion of the transaction, the insider now directly owns 14,289 shares of the company’s stock, valued at $4,715,370. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Bruce D. Broussard sold 18,000 shares of the company’s stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $328.66, for a total value of $5,915,880.00. Following the completion of the transaction, the chief executive officer now directly owns 71,085 shares of the company’s stock, valued at $23,362,796.10. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.wkrb13.com/2018/11/09/humana-hum-updates-fy-2018-earnings-guidance.html.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Further Reading: What does cost of debt say about a company’s financial health?

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply